Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Post by Rambo007on Nov 05, 2018 6:59pm
15 Views
Post# 28927629

2018 3rd unit purchased

2018 3rd unit purchased   {01038765;1}
THC BIOMED INTL LTD.
P.O. Box 20033 Towne Centre
Kelowna, B.C. V1Y 9H2
www.thcbiomed.com
THC Purchases an Additional Lot in its Current Kelowna Location.
Begins Craft Grow Program.
THC.CSE THCBF - OTC TFHC.F
Vancouver, BC – (June 28, 2018) THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE:THC)
announces that it will purchase an additional strata lot in the industrial complex in Kelowna it 
currently occupies and where additional lots were recently purchased on June 12. The purchase is 
scheduled to close on June 29, 2018. The additional lot will be used for production purposes. THC 
is purchasing this property as part of its expansion plan due to high demand for its products. THC 
continues to expand its grow space footprint and hopes to soon conclude the purchase of a green 
house in Ontario.
In light of the recent Royal Assent of Bill C-45, THC continues to work vigorously towards securing 
supply agreements with various provincial governments.
We intend to meet supply demands for adult use recreational cannabis by working with small craft 
growers and giving an opportunity to ordinary Canadians to participate in this emerging market.
THC will work with ordinary Canadians, who would like to be a part of this emerging market .We 
believe that the entrepreneurial spirit Canadians have displayed in the past to bring high quality 
diverse product to the marketplace as witnessed in the wine and similar industries .THC has already 
begun working with entrepreneurial Canadians from diverse backgrounds to establish micro grows 
,we are giving them the support and technical know-how on how to successfully cultivate, establish 
and run successful cannabis micro grows in accordance with the regulations.
We believe smaller batches of high quality product, produced in a culture setting will be essential in 
delivering the experience we expect from our products 
The purchase price is $320,000, plus fees and taxes, ustrata lot is for cash and will not require a 
mortgage.
About THC
THC's vision is to be on the leading edge of scientific research, development of products and services
related to the medical cannabis industry while creating a standard of excellence. As the industry
develops, it will become more important to focus on scientific research and development of products and
services related to medical cannabis. Management believes THC is well-positioned to be in the forefront 
of this rapidly growing industry.
Please visit our website for a more detailed description of our business and services available.
www.thcbiomed.com
Bullboard Posts